251 related articles for article (PubMed ID: 16313878)
1. Advances in therapeutic approaches to ulcerative colitis and Crohn's disease.
Travis S
Curr Gastroenterol Rep; 2005 Dec; 7(6):475-84. PubMed ID: 16313878
[TBL] [Abstract][Full Text] [Related]
2. [Chronic inflammatory bowel disease: Crohn's disease and ulcerative colitis].
Fiasse R; Denis MA; Dewit O
J Pharm Belg; 2010 Mar; (1):1-9. PubMed ID: 20432590
[TBL] [Abstract][Full Text] [Related]
3. Advances in biologic therapy for ulcerative colitis and Crohn's disease.
D'Haens G; Daperno M
Curr Gastroenterol Rep; 2006 Dec; 8(6):506-12. PubMed ID: 17105690
[TBL] [Abstract][Full Text] [Related]
4. [Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].
Bischoff A
MMW Fortschr Med; 2010 Jan; 152(1-2):20. PubMed ID: 20302159
[No Abstract] [Full Text] [Related]
5. [Therapy of chronic inflammatory bowel diseases].
Stange EF
Praxis (Bern 1994); 2002 Nov; 91(47):2029-39. PubMed ID: 12501498
[TBL] [Abstract][Full Text] [Related]
6. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
7. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
8. Expert opinion: experience with 6-mercaptopurine in the treatment of inflammatory bowel disease.
Korelitz BI
World J Gastroenterol; 2013 May; 19(20):2979-84. PubMed ID: 23716977
[TBL] [Abstract][Full Text] [Related]
9. Controversies with aminosalicylates in inflammatory bowel disease.
Lim WC; Hanauer SB
Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
[TBL] [Abstract][Full Text] [Related]
10. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
D'Haens GR; Panaccione R; Higgins PD; Vermeire S; Gassull M; Chowers Y; Hanauer SB; Herfarth H; Hommes DW; Kamm M; Löfberg R; Quary A; Sands B; Sood A; Watermeyer G; Lashner B; Lémann M; Plevy S; Reinisch W; Schreiber S; Siegel C; Targan S; Watanabe M; Feagan B; Sandborn WJ; Colombel JF; Travis S
Am J Gastroenterol; 2011 Feb; 106(2):199-212; quiz 213. PubMed ID: 21045814
[TBL] [Abstract][Full Text] [Related]
11. Drugs for inflammatory bowel disease.
Treat Guidel Med Lett; 2009 Sep; 7(85):65-74; quiz 75-6. PubMed ID: 19696709
[No Abstract] [Full Text] [Related]
12. [New therapies for inflammatory bowel disease].
Matsui T
Nihon Shokakibyo Gakkai Zasshi; 2005 Jul; 102(7):855-65. PubMed ID: 16038431
[No Abstract] [Full Text] [Related]
13. Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective.
Axelrad JE; Roy A; Lawlor G; Korelitz B; Lichtiger S
World J Gastroenterol; 2016 Dec; 22(46):10103-10117. PubMed ID: 28028358
[TBL] [Abstract][Full Text] [Related]
14. [Biological therapy as treatment of inflammatory bowel diseases].
Agnholt J
Ugeskr Laeger; 2008 Jun; 170(24):2152-6. PubMed ID: 18565302
[TBL] [Abstract][Full Text] [Related]
15. Optimizing anti-TNF treatment in inflammatory bowel disease.
Rutgeerts P; Van Assche G; Vermeire S
Gastroenterology; 2004 May; 126(6):1593-610. PubMed ID: 15168370
[TBL] [Abstract][Full Text] [Related]
16. [Azathioprine in chronic inflammatory bowel diseases. Evidence base].
Herrlinger K; Stange EF
Med Klin (Munich); 2000 Apr; 95(4):201-6. PubMed ID: 10808301
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trial.
Strik AS; van de Vrie W; Bloemsaat-Minekus JPJ; Nurmohamed M; Bossuyt PJJ; Bodelier A; Rispens T; van Megen YJB; D'Haens GR;
Lancet Gastroenterol Hepatol; 2018 Jun; 3(6):404-412. PubMed ID: 29606564
[TBL] [Abstract][Full Text] [Related]
18. Drug therapy of inflammatory bowel disease.
Sack DM; Peppercorn MA
Pharmacotherapy; 1983; 3(3):158-76. PubMed ID: 6136027
[TBL] [Abstract][Full Text] [Related]
19. Is thiopurine therapy in ulcerative colitis as effective as in Crohn's disease?
Ghosh S; Chaudhary R; Carpani M; Playford RJ
Gut; 2006 Jan; 55(1):6-8. PubMed ID: 16344570
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.
Fraser AG; Orchard TR; Jewell DP
Gut; 2002 Apr; 50(4):485-9. PubMed ID: 11889067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
